Rates of diagnosis and treatment are low, so there is a need for diagnostic tests and biomarkers for classification and ...

Cambridge-based Biogen is looking to the growth of its Alzheimer’s drug Leqembi to offset the decline of its multiple ...

It promises the benefits of a 10,000-step walk in just 30 minutes. No gym membership required. Just a pair of shoes and a ...

New drugs show promise, and research finds value in vaccines, antivirals, exercise and probiotics.

Regina Barber and Rachel Carlson of Short Wave talk about endangered eagles in Japan, the lifestyles of deep-living ocean ...

A Japanese health ministry panel on Wednesday approved a plan to cut the price of Lecanemab, an Alzheimer's drug codeveloped by Japanese drugmaker Eisai Co. and US industry peer Biogen Inc., by 15 ...

In a major new finding almost a decade in the making, researchers at Harvard Medical School say they’ve found a key that may ...

In further experiments using the mice, those with lithium-deficient brains developed more plaques than did animals with ...

A few limited clinical trials of lithium for Alzheimer’s disease have shown some efficacy, but the lithium compounds they ...

In a provocative new study, Harvard Medical School scientists found that lithium, an element found in some foods and drinking ...

This research offers hope. By finding brain diseases earlier, we might be able to slow them down or manage them better. If ...

SNAP participants showed a slower decline in cognitive function over 10 years, essentially maintaining up to three additional ...